Pre-treatment with LCZ696, an orally active angiotensin receptor neprilysin inhibitor, prevents ischemic brain damageHui‐Yu Bai, Masatsugu Horiuchi, Jun Iwanami et al.|European Journal of Pharmacology|2015Cited by 22